OFI Italian Pharmaceutical

Bergamo, Italy Founded: 1946 • Age: 80 yrs Acquired By Alto Partners
Pharmaceutical products are manufactured by OFI Italian Pharmaceutical in Italy.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About OFI Italian Pharmaceutical

OFI Italian Pharmaceutical is a company based in Bergamo (Italy) founded in 1946 was acquired by Alto Partners in April 2019. OFI Italian Pharmaceutical offers products and services including Dietary Supplements and Medical Devices.

  • Headquarter Bergamo, Italy
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ofi (India) Private Limited
  • Date of Incorporation 03 May, 2013
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$1.45 K (USD)
    85.28
    as on Mar 31, 2022
  • EBITDA
    -$983.64 (USD)
    92.47
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Alto Partners

    (Apr 23, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of OFI Italian Pharmaceutical

OFI Italian Pharmaceutical offers a comprehensive portfolio of products and services, including Dietary Supplements and Medical Devices.

Product name locked
Category locked
Primary

Dietary supplements are developed and manufactured by Officina Farmaceutica Italiana for third parties, ensuring nutritional conformity and quality in formulations

Product name locked
Category locked
Locked

Medical devices are produced by Officina Farmaceutica Italiana through controlled processes to guarantee product efficacy and safety

Funding Insights of OFI Italian Pharmaceutical

Investors in OFI Italian Pharmaceutical

OFI Italian Pharmaceutical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Futurimpresa and Alto Partners.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for OFI Italian Pharmaceutical

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by OFI Italian Pharmaceutical

Investments
Premium access

Investment portfolio details for OFI Italian Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - OFI Italian Pharmaceutical

Premium access

Detailed financials for OFI Italian Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ofi Italian Pharmaceutical Comparisons

OFI Italian Pharmaceutical Primary company
Description
Pharmaceutical products are manufactured by OFI Italian Phar...
Location
Bergamo, Italy
Founded Year
1946
Annual Revenue
Not available
Net Profit
-$1.45 K (USD)
EBITDA
-$983.64 (USD)
Employees
Not available
Premium access

Peer comparison for OFI Italian Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of OFI Italian Pharmaceutical

Premium access

Detailed competitors of OFI Italian Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ofi Italian Pharmaceutical

Premium access

Complete news archive for OFI Italian Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about OFI Italian Pharmaceutical

OFI Italian Pharmaceutical was founded in 1946 and raised its 1st funding round 64 years after it was founded.

OFI Italian Pharmaceutical is headquartered in Bergamo, Italy. It is registered at Bergamo, Lombardy, Italy.

OFI Italian Pharmaceutical was established in 1946 in Bergamo, Italy, within the pharmaceutical sector. Manufacturing operations are centered on producing medicinal products for healthcare applications. The companys activities are conducted from its Italian base, with an online presence maintained through the domain ofi.it. Focus remains on standard pharmaceutical production processes, supporting regional and potential international distribution needs.

OFI Italian Pharmaceutical offers Dietary Supplements and Medical Devices.

OFI Italian Pharmaceutical has 2 investors. Key investors include Futurimpresa, and Alto Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available